Pfizer and BioNTech seek FDA authorization for fourth Covid-19 vaccine doses for people 65 and up

The first data set cited in the release was an analysis of records for more than 1.1 million adults 60 and older by the Israeli Ministry of Health

Keywords
Τυχαία Θέματα
Pfizer, BioNTech,FDA, Covid-19